Patricia Johansson Selected Research

T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)

1/2022	T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level.
12/2020	Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemia.
1/2020	Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
1/2020	Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Johansson Research Topics

Disease

4	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2022 - 01/2020
1	Multiple Myeloma 04/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Cryoglobulinemia 01/2018
1	Wounds and Injuries (Trauma) 01/2013
1	Carcinogenesis 01/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013
1	Disease Progression 01/2013

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
1	venetoclaxIBA 04/2022
1	Kv1.3 Potassium ChannelIBA 04/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Alemtuzumab (Campath)FDA Link 12/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2018
1	GranulinsIBA 01/2013
1	ProgranulinsIBA 01/2013

Therapy/Procedure

1	Therapeutics 04/2022
1	Hematopoietic Stem Cell Transplantation 12/2020
1	Drug Therapy (Chemotherapy) 01/2020